Introduction of the pharmaceutical substance Favipiravir in the State register of medicines

ACTICOMP JSC has been actively involved in the fight against Covid-19, producing not only substances for strategically important medicines that are difficult to access in conditions of logistical difficulties, but also for the direct treatment of coronavirus infection. So, in 2021, the pharmaceutical substance Favipiravir – FS-002146, used and proven to be effective in the complex therapy of Covid-19, was entered into the state register of medicines by the company. The company also produces and develops other antiviral substances that will help the country cope with possible new waves of diseases.